NPI registry status
Active
2026 NPPES data Cardiovascular Disease Physician NPI 1023059417 MD
Verify on CMS → Hanna Mieszczanska, MD
Cardiovascular Disease Physician in Rochester, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 24,795 in Cardiovascular Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
5K
Medicare Part D claims · 648 beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
90.2/100
▲ 7 pts above national avg 83.1 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Hanna Mieszczanska, MD reported a CMS MIPS final score of 90.2/100 - above the 83.1 national average - and filed 4,611 Medicare Part D claims in 2023.
- 90.2/100
- MIPS score · +7 vs avg
- 5K
- Part D claims, 2023
- 90%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Hanna Mieszczanska, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
90 Top 40% higher than 60% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Hanna Mieszczanska, MD sits
This provider among cardiovascular disease physician peers
Across the 8,753 cardiovascular disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Hanna Mieszczanska, MD writes more Part D claims than 71% of them and scores higher on MIPS quality than 61% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one cardiovascular disease physician peer from a representative sample of 60; the gold marker is Hanna Mieszczanska, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Hanna Mieszczanska, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Hanna Mieszczanska, MD?
High performer (top quartile)Primary specialty
Cardiovascular Disease Physician
Medicare Part D claims
4,611 52% vs specialty avg
MIPS final score
90.2/100 7.1 pts vs avg
Specialty distribution in New York
How Cardiovascular Disease Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Hanna Mieszczanska, MD's 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average
- MIPS Final Score
- 90.2/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Cardiovascular Disease Physician) - 90.2/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Hanna Mieszczanska, MD appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding MD credentials at 601 ELMWOOD AVE, Rochester, NY, 14642, with a listed phone of (585) 275-4751. NPI 1023059417 was issued on 06/09/2006.
Medicare Part D records for calendar year 2023 show 4,611 prescription claims written by this provider, covering 648 Medicare beneficiaries and totaling roughly $641K in drug spend, split 10% brand-name and 90% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 90.2/100 for the 2023 performance year (Quality 74.7, Cost 70.3), compared with the national average of 83.1.
Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1023059417 |
|---|---|
| Specialty | Cardiovascular Disease Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 06/09/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
90.2334
Final Score
Avg: 83.1
74.688
Quality
70.2532
Cost
100
Promoting Interoperability
Reporting: Group practice
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Hanna Mieszczanska, MD. To verify Hanna Mieszczanska, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Hanna Mieszczanska, MD - brand share 10.0%
Cardiovascular Disease Physician average
10% brand-name claims vs 90% generic, on 4,611 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
4,611
Total Claims
$641K
Total Drug Cost
648
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 11,955
- Total Day Supply
- 357,936
- Brand vs Generic
- 10% brand / 90% generic
- Brand Drug Cost
- $507K
- Generic Drug Cost
- $134K
Patient Demographics
- Average Patient Age
- 74.3 years
- Avg HCC Risk Score
- 1.28
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 55, 65-74: 278, 75-84: 236, 85+: 79
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Hanna Mieszczanska, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Rosuvastatin Calcium
Rosuvastatin Calcium
536 claims
- Metoprolol Succinate
Metoprolol Succinate
488 claims
- Amlodipine Besylate
Amlodipine Besylate
399 claims
- Eliquis
Eliquis
240 claims
- Atorvastatin Calcium
Atorvastatin Calcium
224 claims
- Ezetimibe 209
Ezetimibe
209 claims
- Torsemide 180
Torsemide
180 claims
- Carvedilol 171
Carvedilol
171 claims
| Drug | Claims |
|---|---|
| Rosuvastatin Calcium | 536 |
| Metoprolol Succinate | 488 |
| Amlodipine Besylate | 399 |
| Eliquis Apixaban | 240 |
| Atorvastatin Calcium | 224 |
| Ezetimibe | 209 |
| Torsemide | 180 |
| Carvedilol | 171 |
| Spironolactone | 153 |
| Olmesartan Medoxomil | 143 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cardiovascular Disease Physician Overview
How Hanna Mieszczanska, MD fits within the Cardiovascular Disease Physician landscape nationally.
24,795
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider
Hanna Mieszczanska, MD's 4,611 claims are above the specialty average of 3,033.
Nearby Cardiovascular Disease Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Mieszczanska.
Dr. Michael Aaron
MD
West Islip, NY
Dr. Vivian Abascal
MD
Richmond Hill, NY
Dr. Joseph Abboud
MD
Brooklyn, NY
Dr. Mohamed Abdel-Aal Ahmed
M.D.
Buffalo, NY
Dr. Khaled Abdulla
M.D.
Rochester, NY
Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Cardiovascular Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New York
Frequently Asked Questions
What is Hanna Mieszczanska, MD's specialty? ▼
Hanna Mieszczanska, MD specializes in Cardiovascular Disease Physician and practices in Rochester, New York. Credentials: MD.
How much does Hanna Mieszczanska, MD prescribe under Medicare Part D? ▼
In 2023, Hanna Mieszczanska, MD wrote 4,611 Medicare Part D claims totaling $641K in drug costs for 648 beneficiaries.
What is Hanna Mieszczanska, MD's Medicare quality score? ▼
Hanna Mieszczanska, MD has a CMS MIPS Final Score of 90.2/100 (Quality: 74.7, Cost: 70.3). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Hanna Mieszczanska, MD located? ▼
Hanna Mieszczanska, MD is located at 601 ELMWOOD AVE, Rochester, NY, 14642. Phone: (585) 275-4751.
What is Hanna Mieszczanska, MD's NPI number? ▼
Hanna Mieszczanska, MD's National Provider Identifier (NPI) is 1023059417, issued on 06/09/2006.
Does Hanna Mieszczanska, MD prescribe more brand-name or generic drugs? ▼
Hanna Mieszczanska, MD's prescribing is 10% brand-name and 90% generic drugs by claim count, with $507K in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US? ▼
There are 24,795 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does Hanna Mieszczanska, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Hanna Mieszczanska, MD's most frequently prescribed drugs include Rosuvastatin Calcium, Metoprolol Succinate, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Hanna Mieszczanska, MD accept Medicare? ▼
Hanna Mieszczanska, MD appears in CMS Medicare data with 4,611 Part D claims and 648 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Hanna Mieszczanska, MD's credentials? ▼
Hanna Mieszczanska, MD's NPI is 1023059417 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.